Thus, we tested the association of variants in FOXP3 microsatellites, CTLA4 SNPs and HLA genotype in 284 melanoma patients and their association with prognosis and survival of patients with melanoma who received adjuvant therapy with IFNa. The gene discussed is IFNA1; the disease is melanoma.